http://extrobritannia.blogspot.com/2008/01/nextrobritannia-after-few-months-of.html

ExtroBritannia - February 16, 2008 Meeting

Date and Time: Saturday, February 16, 2008 at 12:30 GMT

Location: Penderel's Oak, 283-288 High Holborn, London WC1V 7HJ

Description:

NEXTROBRITANNIA - After a few months of inactivity, the UKTA is ready to spring back into action. What's the next step? NextroBritannia, obviously...

Saturday the 16th of February 2008, from 12:30 at the Penderel's Oak in Holborn, London (see below for address and map). Everyone welcome.

The plan is to catch up with each other's news over lunch and then discuss the way forward. The points on the agenda are:

- The possibility of a rotating chair system for organising meetings and events
- How to structure meetings and events
- Candidates for the future UKTA roles
- Date, time, place and person responsible for organising the next meeting
- Any other business

Penderel's Oak
283-288 High Holborn
London WC1V 7HJ
Tel: 0207 242 5669
Nearest tube: Holborn
MAP

If it's your first time at an ExtroBritannia event, look out for a copy of Aubrey de Grey's "Ending Aging" at our table.

http://www.srcf.ucam.org/cuths/events/

Cambridge University Transhumanist Society Talk hosted jointly with Trinity College Science Society. Dr. Aubrey de Grey Presents "Prospects for extending healthy life - a lot"

Date and Time: Thursday, January 24, 2008 at 8:00pm GMT

Location: Winstanley Lecture Theatre, Trinity College, Cambridge, England

Description: Abstract:

It may seem premature to be discussing approaches to the effective elimination of human aging as a cause of death at a time when essentially no progress has yet been made in even postponing it. However, two aspects of human aging combine to undermine this assessment. The first is that aging is happening to us throughout our lives but only results in appreciable functional decline after four or more decades of life: this shows that we can postpone the functional decline caused by aging arbitrarily well without knowing how to prevent aging completely, but instead by increasingly thorough molecular and cellular repair. The second is that the typical rate of refinement of dramatic technological breakthroughs is rather reliable (so long as public enthusiasm for them is abundant) and is fast enough to change such technologies (be they in medicine, transport, or computing) almost beyond recognition within a natural human lifespan. In this talk I will explain, first, why (presuming adequate funding for the initial preclinical work) therapies that can add 30 healthy years to the remaining lifespan of healthy 55-year-olds may arrive within the next few decades, and, second, why those who benefit from those therapies will very probably continue to benefit from progressively improved therapies indefinitely and thus avoid debilitation or death from age-related causes at any age.